Compile Data Set for Download or QSAR
Report error Found 104 Enz. Inhib. hit(s) with all data for entry = 13055
TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755339((R)-2-((S)-2-(4-((3-aminopropyl)amino)isoindolin-2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755337((R)-2-((S)-2-(4-(3-aminopropoxy)phenyl)-2-(isoindo...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755336((R)-2-((S)-2-(3-((3-aminopropyl)amino)phenyl)-2-(i...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755335((R)-2-((S)-2-(4-(3-aminopropoxy)phenyl)-2-(isoindo...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755334((R)—N-(2,6-difluoro-4-hydroxybenzyl)-2-((R)-2-(iso...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755333((R)—N-(2,6-difluoro-4-hydroxybenzyl)-2-((S)-2-(iso...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755345((R)—N-(2,6-difluoro-4-hydroxybenzyl)-5-guanidino-2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755343((2R)—N-(2,6-difluoro-4-hydroxybenzyl)-5-((Z)-2-(et...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755342((R)-2-((R)-2-(3-((3-aminopropyl)amino)phenyl)-2-(i...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755341((R)-2-((S)-2-(3-((3-aminopropyl)amino)phenyl)-2-(i...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755340((R)-2-((S)-2-(5-((3-aminopropyl)amino)isoindolin-2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755323(2,2',2″-(10-((14R,16R)-22-(4-((1S,4R,Z)-9-amino-4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755322(2,2',2″-(10-(2-((2-((2R,5R)-5-(2-((3-(4-((1S,4R,Z)...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755321(US20250213735, Compound 51)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755320(2,2',2″-(10-(2-((3-(((R)-4-amino-1-((3-(4-((1S,4R,...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755319(2,2',2″-(10-(4-((2-(4-((3-(4-((1S,4R,Z)-9-amino-4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755318(2,2',2″-(10-(2-((3-(((R)-1-((3-(4-((1S,4R,Z)-9-ami...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755317(2,2',2″-(10-(2-((3-((3-(4-((1S,4R,Z)-9-amino-4-((2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755316(US20250213735, Compound 46)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755331((R)—N-(4-hydroxybenzyl)-2-((S)-2-(isoindolin-2-yl)...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755330((2R)—N-(4-hydroxybenzyl)-2-(2-(isoindolin-2-yl)-2-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755329(2,2',2″-(10-(2-((3-(4-((1S,4R,Z)-9-amino-4-((4-hyd...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755328(2,2',2″-(10-(2-((6-((2-(4-((1S,4R,Z)-9-amino-4-((4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755327(2,2',2″-(10-(2-((6-((4-(4-((1S,4R,Z)-9-amino-4-((4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755326(2,2',2″-(10-(2-((5-((3-(4-((1S,4R,Z)-9-amino-4-((2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755325(2,2',2″-(10-(2-((2-((3-((3-(4-((1S,4R,Z)-9-amino-4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755324(2,2',2″-(10-((8R,11R,14R)-19-(4-((1S,4R,Z)-9-amino...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755371(US20250213735, Compound 92)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755370((2R)-2-(2-(4-(tert-butyl)piperidin-1-yl)-2-phenyla...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755275(US20250213735, Compound 6)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755274(2,2',2″-(10-(2-((6-(4-((3-(4-((1S,4R,Z)-9-amino-4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755273(US20250213735, Compound 4)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755272(2,2',2″-(10-(2-((6-((4-((3-((1R,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755271(2,2',2″-(10-(2-((6-((4-((3-((1S,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755270(2,2',2″-(10-(2-((6-((2-((3-((3-((1S,4R,Z)-9-amino-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755268(US20250213735, Compound 1A)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755283(2,2',2″-(10-(2-((2-(3-((3-((3-((11R,14S,Z)-6-amino...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755282(2,2',2″-(10-(2-(((R)-5-amino-6-((3-((3-((11R,14S,Z...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755281(2,2',2″-(10-(2-((6-((3-(3-((1S,4R,Z)-9-amino-4-((4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755280(2,2',2″-(10-(2-((6-((3-((3-((1S,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755279(2,2',2″-(10-(9-((3-((2-((1S,4R,Z)-9-amino-4-((2,6-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755278(2,2',2″-(10-(2-((6-((4-((2-((1S,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755276(A single isomer of 2,2',2″-(10-(2-((2-(2-(3-(4-((4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755307(2,2',2″-(10-(2-((6-((2-((3-(4-((1S,4R,Z)-9-amino-4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755306(2,2',2″-(10-(2-((6-((3-(4-((1S,4R,Z)-9-amino-4-((2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755305(2,2',2″-(10-(2-((6-(4-(4-(3-(4-((1S,4R,Z)-9-amino-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755304(2,2',2″-(10-(2-((6-((2-((3-((2-((1S,4R,Z)-9-amino-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755303(2,2',2″-(10-(2-((6-((3-((2-((1S,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755302(A single isomer of 2,2',2″-(10-(2-((3-(((R)-1-((4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755301(A single isomer of 2,2',2″-(10-(2-((3-(((R)-1-((4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

Displayed 1 to 50 (of 104 total ) | Next | Last >>
Jump to: